Perimenopause Rage

Written and Fact-Checked by: Jenna Carberg

What Is Perimenopause Rage?

“Perimenopause rage” and “menopause rage” describe sudden, intense anger or irritability that some women notice in their 40s and early 50s: snapping at family over small things, feeling furious and not knowing why, or a short fuse that doesn’t feel like you. It can be distressing and confusing, especially if you’ve never felt this way before.

It is important to know two things. First, “rage” is not a medical diagnosis or a research term. Scientists study “irritability” and, less often, “anger.” Second, irritability is a real, recognized mood symptom, and there are ways to find out what’s behind it and get relief.

What the Research Actually Shows

  • Irritability is treated as a real clinical symptom. Researchers have built a dedicated rating scale for irritability based on descriptions from women with mood problems linked to the menstrual cycle, childbirth and menopause. It measures annoyance, anger, tension, hostility and sensitivity to noise and touch.
  • Irritability tends to show up with other symptoms. In a study of 639 women ages 45 to 54, irritability, night sweats, hot flashes and trouble sleeping were each linked to higher depression scores.
  • Anger can rise with menopause symptom burden. In a study of 200 menopausal women, anger and loneliness were both higher in women with more menopause symptoms.

What we don’t have: no reliable figure for how many women experience irritability or anger during perimenopause. Any specific percentage you see for “menopause rage” can’t be traced to solid research.

Why It Might Happen

Researchers have several theories, and the evidence for each is still limited.

Hormone Swings, Not Just Low Hormones

Estrogen and progesterone don’t simply fall during perimenopause; they rise and drop unpredictably. Studies suggest mood symptoms are worse when hormone levels are more variable. In one study of perimenopausal women, greater swings in estradiol predicted more depressive symptoms, but only in women who were also dealing with major stressful life events.

This mirrors research on PMDD, where a landmark trial showed mood symptoms are an abnormal response to normal hormone changes rather than abnormal hormone levels. Some women appear to be especially sensitive to hormone shifts.

Sleep Loss and Hot Flashes

Night sweats and hot flashes can break up sleep, and poor sleep makes almost everyone more irritable. Researchers describe a “domino” effect in which hot flashes disturb sleep and sleep loss increases vulnerability to mood problems. Sleep problems predict mood symptoms more strongly than hot flashes do.

Stress and Life Changes

Midlife often brings caregiving for children and aging parents, work pressure and relationship changes. Stress appears to amplify hormone-related mood sensitivity.

Connection to Postpartum Rage and PMDD

If you experienced postpartum rage, postpartum depression or PMDD, you may wonder whether perimenopause will bring the same feelings back. Researchers group premenstrual, postpartum and perimenopausal mood problems together because they all occur during times of major hormone change.

  • A review of reproductive mood disorders says women with past or current PMDD may be more sensitive to the hormone drop of late perimenopause, and advises clinicians to watch for worsening symptoms.
  • In a study of 567 women with bipolar disorder, a history of premenstrual mood symptoms was linked to about 6 times the odds of a mood episode during perimenopause, and a history of postpartum depression was linked to about 2.6 times the odds of depression then. These findings are from women with bipolar disorder and may not apply to everyone.

No study has followed women with postpartum rage specifically into perimenopause. But if hormone changes have affected your mood before, it is worth telling your doctor as you enter your 40s.

When Anger May Signal Something Else

Irritability can be a sign of a treatable condition, so a checkup is worthwhile.

Depression and Anxiety

Irritability is a common symptom of depression and anxiety, both of which become more likely during the menopause transition. See perimenopause depression and perimenopause anxiety.

Bipolar Disorder

Perimenopause can be a vulnerable time for women with bipolar disorder. Studies have found more depressive episodes, more time with symptoms and more severe mood episodes during the later transition. Irritability with a reduced need for sleep, racing thoughts, unusual energy or impulsive behavior should be evaluated promptly.

Thyroid Disease

An overactive thyroid, particularly Graves’ disease, is associated with irritability, mood changes and insomnia, and it raised the risk of anxiety, depression and bipolar disorder in a large national study. A simple blood test can check. That said, abnormal thyroid tests were not broadly linked to menopause symptoms in the large SWAN study, so thyroid is one possibility among several, not the usual explanation.

What Helps

No clinical trial has tested a treatment specifically for perimenopausal irritability or anger. The options below come from trials of related symptoms such as depression, anxiety and hot flashes.

  • Treating sleep problems and night sweats may ease irritability, given how closely sleep and mood are linked.
  • Therapy. CBT programs for menopausal symptoms have improved depression, sleep and emotional symptoms in trials. Therapy can also help with anger and stress management.
  • Antidepressants. SSRIs and SNRIs treat depression and anxiety and reduce hot flashes, though trials on overall menopausal mood symptoms have had mixed results.
  • Hormone therapy. It is the most effective treatment for hot flashes. In the KEEPS trial, oral estrogen modestly improved depression and anxiety symptoms, but anger and irritability weren’t reported separately. Hormone therapy isn’t approved for mood symptoms.
  • Exercise, especially mind-body exercise like yoga, has reduced depressive symptoms in midlife women.
  • Tracking your symptoms alongside your cycle, sleep and hot flashes can help you and your doctor spot patterns.

Find a therapist who treats women’s mood and hormone-related symptoms

Talking to Your Doctor

It helps to describe:

  • How often you feel irritable or angry and how intense it is
  • Changes in your periods, hot flashes and sleep
  • Any history of PMDD, postpartum depression or postpartum rage, depression, anxiety or bipolar disorder
  • Other symptoms like low mood, anxiety, palpitations or weight changes

If anger ever feels out of control, or you have thoughts of harming yourself or someone else, reach out right away. Call or text 988 for the Suicide & Crisis Lifeline, available 24 hours a day, or call 911 in an emergency.

Frequently Asked Questions

Is menopause rage real?

Irritability and anger during perimenopause are real experiences and irritability is a recognized clinical symptom, but “rage” is not a medical diagnosis and there is no reliable figure for how common it is.

Why am I so angry in perimenopause?

Possible reasons include hormone swings, poor sleep from night sweats, stress, and conditions such as depression, anxiety or thyroid disease. A doctor can help sort out the cause.

Does HRT help perimenopause rage?

There is no trial testing hormone therapy for anger specifically. It relieves hot flashes, which can improve sleep, and one large trial found modest improvements in depression and anxiety with oral estrogen.

Is perimenopause rage related to PMDD?

They may share a sensitivity to hormone changes. Women with a history of PMDD may be more likely to have mood symptoms in late perimenopause.

How long does perimenopause rage last?

There isn’t research tracking irritability over time specifically. Treating underlying sleep problems, hot flashes, depression or anxiety often helps.

PostpartumDepression.org Team
Written by:

Jenna Carberg was diagnosed with postpartum depression following the birth of her daughter in 2016. It was a healthy birth but in the following days, Jenna's mood changed quickly. Doctors suggested that it might be the "baby blues", but her husband Chris suggested she seek a second opinion. Jenna was diagnosed with postpartum depression and began a journey that lasted 9 long months with significant ups and downs. Jenna's mental health care and her experiences became a passion for her to share with the world. She and her husband Chris founded PostpartumDepression.org as a support website designed to help women suffering in silence and their loved ones.

  1. Miller C, Carlson K. “Premenstrual Disorders.” StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated August 9, 2026. https://www.ncbi.nlm.nih.gov/books/NBK532307/. Accessed September 15, 2026. (Reused from held corpus.)
  2. Sander B, Gordon JL. “Premenstrual Mood Symptoms in the Perimenopause.” Current Psychiatry Reports. 2021;23(11):73. https://doi.org/10.1007/s11920-021-01285-1.
  3. Born L, Koren G, Lin E, Steiner M. “A new, female-specific irritability rating scale.” Journal of Psychiatry & Neuroscience. 2008;33(4):344-354. https://pubmed.ncbi.nlm.nih.gov/18592028/.
  4. Ozcan H, Savci H, Canik M, Ayan M, Bas CF. “Comparison of the relationship between menopausal symptoms and loneliness and anger.” Perspectives in Psychiatric Care. 2022;58(4):1900-1906. https://doi.org/10.1111/ppc.13004.
  5. Spyropoulou AC, Zervas IM, Christodoulakos G, Lambrinoudaki I, Rizos D, Koundi K, Sanida E, Creatsas G, Soldatos CR. “Irritability in menopause: an investigation of its relation to menopausal, hormonal and physical factors.” Psychotherapy and Psychosomatics. 2009;78(2):128-130. https://doi.org/10.1159/000203120. Blocked: PubMed record has no abstract (Letter type); publisher page paywalled ($45). No finding used — title only.
  6. Brown JP, Gallicchio L, Flaws JA, Tracy JK. “Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife.” Maturitas. 2009;62(2):184-189. https://doi.org/10.1016/j.maturitas.2008.11.019.
  7. Lee MS, Kim JH, Park MS, Yang J, Ko YH, Ko SD, Joe SH. “Factors influencing the severity of menopause symptoms in Korean post-menopausal women.” Journal of Korean Medical Science. 2010;25(5):758-765. https://doi.org/10.3346/jkms.2010.25.5.758.
  8. Parazzini F. “Resveratrol, tryptophanum, glycine and vitamin E: a nutraceutical approach to sleep disturbance and irritability in peri- and post-menopause.” Minerva Ginecologica. 2015;67(1):1-5. https://pubmed.ncbi.nlm.nih.gov/25660429/.
  9. Harder JA, Fichorova RN, Srivastava A, Wiley A, Burdick KE, Locascio JJ, Joffe H. “Brain-derived neurotrophic factor and mood in perimenopausal depression.” Journal of Affective Disorders. 2022;300:145-149. https://doi.org/10.1016/j.jad.2021.12.092.
  10. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. “Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.” The New England Journal of Medicine. 1998;338(4):209-216. https://doi.org/10.1056/NEJM199801223380401. (Reused from held corpus; studied premenstrual syndrome, not perimenopause.)
  11. Allshouse A, Pavlovic J, Santoro N. “Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms.” Obstetrics and Gynecology Clinics of North America. 2018;45(4):613-628. https://doi.org/10.1016/j.ogc.2018.07.004.
  12. Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Leserman J, Girdler SS. “Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition.” Menopause. 2016;23(3):257-266. https://doi.org/10.1097/GME.0000000000000528.
  13. Yap S, Luki J, Hanstock CC, Seres P, Shandro T, Hanstock SEC, Lirette A, Zhao HH, Aitchison KJ, Le Melledo JM. “Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women.” Frontiers in Psychiatry. 2021;12:763562. https://doi.org/10.3389/fpsyt.2021.763562.
  14. Soares CN, Bajbouj M, Schoof N, Kishore A, Caetano C. “Impact of sleep disturbances on health-related quality of life in postmenopausal women: a systematic review.” Menopause. 2026;33(1):118-128. https://doi.org/10.1097/GME.0000000000002633.
  15. Bonanni E, Schirru A, Di Perri MC, Bonuccelli U, Maestri M. “Insomnia and hot flashes.” Maturitas. 2019;126:51-54. https://doi.org/10.1016/j.maturitas.2019.05.001.
  16. Kalay AE, Demir B, Haberal A, Kalay M, Kandemir O. “Efficacy of citalopram on climacteric symptoms.” Menopause. 2007;14(2):223-229. https://doi.org/10.1097/01.gme.0000243571.55699.4a.
  17. Suvanto-Luukkonen E, Koivunen R, Sundström H, Bloigu R, Karjalainen E, Häivä-Mällinen L, Tapanainen JS. “Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.” Menopause. 2005;12(1):18-26. https://doi.org/10.1097/00042192-200512010-00006.
  18. Burt VK, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Stewart DE. “Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years.” Psychosomatics. 2005;46(4):345-354. https://doi.org/10.1176/appi.psy.46.4.345.
  19. Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll-Desrosiers AR, Rothschild AJ. “Progression of female reproductive stages associated with bipolar illness exacerbation.” Bipolar Disorders. 2012;14(5):515-526. https://doi.org/10.1111/j.1399-5618.2012.01026.x.
  20. Freeman MP, Smith KW, Freeman SA, McElroy SL, Kmetz GE, Wright R, Keck PE Jr. “The impact of reproductive events on the course of bipolar disorder in women.” The Journal of Clinical Psychiatry. 2002;63(4):284-287. https://doi.org/10.4088/jcp.v63n0403.
  21. Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S. “Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.” PLoS Medicine. 2015;12(6):e1001833. https://doi.org/10.1371/journal.pmed.1001833.
  22. The North American Menopause Society. “The 2023 nonhormone therapy position statement of The North American Menopause Society.” Menopause. 2023;30(6):573-590. https://doi.org/10.1097/GME.0000000000002200.
  23. Kim DS, Kim NY, Han DH, Kim HJ, Yu ES, Kim SM. “Efficacy of cognitive behavioral therapy for menopausal symptoms and quality of life in Korean perimenopausal women: A pilot randomized controlled trial.” Maturitas. 2024;189:108103. https://doi.org/10.1016/j.maturitas.2024.108103.
  24. Green SM, Donegan E, Frey BN, Fedorkow DM, Key BL, Streiner DL, McCabe RE. “Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial.” Menopause. 2019;26(9):972-980. https://doi.org/10.1097/GME.0000000000001363.
  25. Marsh WK, Templeton A, Ketter TA, Rasgon NL. “Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report.” Journal of Psychiatric Research. 2008;42(3):247-251. https://doi.org/10.1016/j.jpsychires.2006.12.006.
  26. Marsh WK, Gershenson B, Rothschild AJ. “Symptom severity of bipolar disorder during the menopausal transition.” International Journal of Bipolar Disorders. 2015;3(1):35. https://doi.org/10.1186/s40345-015-0035-z.
  27. Koukopoulos A, Tondo L, Sani G, Janiri D, De Chiara L, Baldessarini RJ. “Affective illness onset in women during the pre-, peri-, and post-menopausal phases.” Nordic Journal of Psychiatry. 2026;80(1):59-65. https://doi.org/10.1080/08039488.2025.2589851.
  28. Gordon-Smith K, Perry A, Di Florio A, Craddock N, Jones I, Jones L. “Associations between lifetime reproductive events among postmenopausal women with bipolar disorder.” Archives of Women’s Mental Health. 2025;28(3):573-581. https://doi.org/10.1007/s00737-024-01533-2.
  29. Robertson Blackmore E, Craddock N, Walters J, Jones I. “Is the perimenopause a time of increased risk of recurrence in women with a history of bipolar affective postpartum psychosis? A case series.” Archives of Women’s Mental Health. 2008;11(1):75-78. https://doi.org/10.1007/s00737-008-0215-2.
  30. Frey BN, Dias RS. “Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder.” Bipolar Disorders. 2014;16(1):48-57. https://doi.org/10.1111/bdi.12151.
  31. Lee JY, Hong M, Jung YH, Sohn SY. “Risk of psychiatric disorders in patients with graves’ disease: A nationwide population-based analysis.” Journal of Affective Disorders. 2025;385:119386. https://doi.org/10.1016/j.jad.2025.119386.
  32. Alci D, Eroglu M, Asik M. “Temperament Traits as Key Modulators of Depression and Anxiety in Hyperthyroidism: Implications for Personalized Treatment.” Cureus. 2025;17(3):e81503. https://doi.org/10.7759/cureus.81503.
  33. Yazkan Akgül G, Köprülü Ö. “Examination of quality of life and psychiatric symptoms in childhood Graves’ disease.” Journal of Pediatric Endocrinology & Metabolism. 2024;37(5):445-450. https://doi.org/10.1515/jpem-2023-0550.
  34. Sowers M, Luborsky J, Perdue C, Araujo KL, Goldman MB, Harlow SD; SWAN. “Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN.” Clinical Endocrinology. 2003;58(3):340-347. https://doi.org/10.1046/j.1365-2265.2003.01718.x.
  35. Culpepper L. “Generalized anxiety disorder and medical illness.” The Journal of Clinical Psychiatry. 2009;70 Suppl 2:20-24. https://doi.org/10.4088/jcp.s.7002.04.
  36. 988 Suicide & Crisis Lifeline. “988 Lifeline.” https://988lifeline.org/. Accessed September 15, 2026. (Reused from held corpus.)
  37. Rapkin AJ, Mikacich JA, Moatakef-Imani B, Rasgon N. “The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.” Current Psychiatry Reports. 2002;4(6):419-428. https://doi.org/10.1007/s11920-002-0069-7.

Get Answers to Your Postpartum Depression Questions

Find a Therapist